Your browser doesn't support javascript.
loading
PcG methylation of the HIST1 cluster defines an epigenetic marker of acute myeloid leukemia.
Tiberi, G; Pekowska, A; Oudin, C; Ivey, A; Autret, A; Prebet, T; Koubi, M; Lembo, F; Mozziconacci, M-J; Bidaut, G; Chabannon, C; Grimwade, D; Vey, N; Spicuglia, S; Calmels, B; Duprez, E.
Afiliación
  • Tiberi G; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France.
  • Pekowska A; CIML, CNRS UMR6102, INSERM U631, Aix-Marseille Université, Marseille, France.
  • Oudin C; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France.
  • Ivey A; 1] Department of Medical and Molecular Genetics, King's College London School of Medicine, London, UK [2] GSTS Pathology, Guy's Hospital, London, UK.
  • Autret A; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France.
  • Prebet T; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France.
  • Koubi M; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France.
  • Lembo F; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France.
  • Mozziconacci MJ; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France.
  • Bidaut G; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France.
  • Chabannon C; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France.
  • Grimwade D; Department of Medical and Molecular Genetics, King's College London School of Medicine, London, UK.
  • Vey N; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France.
  • Spicuglia S; CIML, CNRS UMR6102, INSERM U631, Aix-Marseille Université, Marseille, France.
  • Calmels B; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France.
  • Duprez E; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France.
Leukemia ; 29(5): 1202-6, 2015 May.
Article en En | MEDLINE | ID: mdl-25482132

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Histonas / Leucemia Mieloide Aguda / Familia de Multigenes / Metilación de ADN / Epigénesis Genética Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Histonas / Leucemia Mieloide Aguda / Familia de Multigenes / Metilación de ADN / Epigénesis Genética Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Francia